+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Bullous Pemphigoid Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767273
  • Report
  • April 2019
  • Region: Global
  • 51 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Akari Therapeutics Plc
  • Celgene Corp
  • Dompe Farmaceutici SpA
  • Eli Lilly and Co
  • F. Hoffmann-La Roche Ltd
  • Fresenius SE & Co KGaA
  • MORE
The global clinical trial report- “2019 Bullous Pemphigoid Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Bullous Pemphigoid. It presents in-depth analysis of Bullous Pemphigoid clinical trials across markets and companies. The research work is for providing complete understanding into trends in Bullous Pemphigoid.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Bullous Pemphigoid clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Bullous Pemphigoid

The research work is prepared through extensive and continuous research on Bullous Pemphigoid trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Bullous Pemphigoid patients are identified
  • The report includes panorama of Bullous Pemphigoid clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Bullous Pemphigoid clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Akari Therapeutics Plc
  • Celgene Corp
  • Dompe Farmaceutici SpA
  • Eli Lilly and Co
  • F. Hoffmann-La Roche Ltd
  • Fresenius SE & Co KGaA
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Bullous Pemphigoid Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Bullous Pemphigoid Clinical Trials by Region
2.2.2 Average Enrollment of Bullous Pemphigoid Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Bullous Pemphigoid Treatment, 2019

3. Region wise Bullous Pemphigoid Clinical Trials
3.1 Asia Pacific Bullous Pemphigoid Clinical Trials by Country
3.2 Europe Bullous Pemphigoid Clinical Trials by Country
3.3 North America Bullous Pemphigoid Clinical Trials by Country
3.4 Middle East and Africa Bullous Pemphigoid Clinical Trials by Country
3.5 South and Central America Bullous Pemphigoid Clinical Trials by Country

4. Bullous Pemphigoid Clinical Trial Trends
4.1 Start Year wise Bullous Pemphigoid Clinical Trials
4.2 Phase wise Bullous Pemphigoid Clinical Trials
4.3 Trial Status wise Bullous Pemphigoid Clinical Trials
4.4 Trial Type wise Bullous Pemphigoid Clinical Trials

5. Bullous Pemphigoid Average Enrollment Trends
5.1 Average Enrollment in Bullous Pemphigoid Trials by Year
5.2 Average Enrollment in Bullous Pemphigoid Trials by Phase
5.3 Average Enrollment in Bullous Pemphigoid Trials by Status
5.4 Average Enrollment in Bullous Pemphigoid Trials by Type of Trial

6. Companies Participating in Bullous Pemphigoid Clinical Trials
6.1 Bullous Pemphigoid Trials by Sponsor Type
6.2 Bullous Pemphigoid Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Bullous Pemphigoid Trials- Phase 1
7.2 Bullous Pemphigoid Trials- Phase 2
7.3 Bullous Pemphigoid Trials- Phase 3
7.4 Bullous Pemphigoid Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Bullous Pemphigoid Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Bullous Pemphigoid Clinical Trials and Enrolment
Figure 5: Europe - Country wise Bullous Pemphigoid Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Bullous Pemphigoid Clinical Trials and Enrolment
Figure 7: North America - Country wise Bullous Pemphigoid Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Bullous Pemphigoid Clinical Trials and Enrolment
Figure 9: Bullous Pemphigoid Clinical Trials by Phase
Figure 10: Bullous Pemphigoid Clinical Trials by Trial Status
Figure 11: Bullous Pemphigoid Clinical Trials by Type
Figure 12: Bullous Pemphigoid Clinical Trials by Sponsor Type
Figure 13: Bullous Pemphigoid Clinical Trials by Leading Sponsors
Figure 14: Bullous Pemphigoid Average Enrollment by Phase
Figure 15: Bullous Pemphigoid Average Enrollment by Trial Status
Figure 16: Bullous Pemphigoid Average Enrollment by Type
Figure 17: Bullous Pemphigoid- Average Enrolment by Type of Sponsors
Figure 18: Bullous Pemphigoid- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Bullous Pemphigoid Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Bullous Pemphigoid Clinical Trials and Enrolment
Table 5: Europe - Country wise Bullous Pemphigoid Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Bullous Pemphigoid Clinical Trials and Enrolment
Table 7: North America - Country wise Bullous Pemphigoid Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Bullous Pemphigoid Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Bullous Pemphigoid Average Enrollment by Phase
Table 15: Bullous Pemphigoid Average Enrollment by Trial Status
Table 16: Bullous Pemphigoid Average Enrollment by Type
Table 17: Bullous Pemphigoid- Average Enrolment by Type of Sponsors
Table 18: Bullous Pemphigoid- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3
  • Akari Therapeutics Plc
  • Assign Clinical Research GmbH
  • Celgene Corp
  • Dompe Farmaceutici SpA
  • Eli Lilly and Co
  • F. Hoffmann-La Roche Ltd
  • Fresenius SE & Co KGaA
  • GBA Gesellschaft fur Bioanalytik mbh
  • Glenmark Pharmaceuticals Ltd
  • Immune Pharmaceuticals Inc
Note: Product cover images may vary from those shown
Adroll
adroll